Clinical trials
Mesothelioma, Malignant trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Chinese Academy of Medical Sciences | 1 |
| Chinese PLA General Hospital | 1 |
| ImmVira Pharma Co. Ltd | 1 |
| Multitude Therapeutics Inc. | 1 |
| Sun Yat-sen University | 1 |
| Tianjin Medical University Second Hospital | 1 |
| UTC Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 8 |
| Ovarian Neoplasms | 3 |
| Endometrial Neoplasms | 2 |
| Lymphoma | 2 |
| Pancreatic Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
| Bile Duct Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.